Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Spontaneous subcapsular splenic hematoma associated with filgrastim in a patient undergoing allogeneic hematopoietic stem cell transplantation.

Ganetsky A, Kucharczuk C, Del Percio S, Frey N, Gill S.

Ann Pharmacother. 2013 May;47(5):e22. doi: 10.1345/aph.1S005. Epub 2013 Apr 12.

PMID:
23585644
2.

A rare but severe complication of filgrastim in a healthy donor: splenic rupture.

Akyol G, Pala C, Yildirim A, Keklika M, Demir K, Dortdudak S, Sivgin S, Kaynar L, Esera B, Unal A, Cetin M.

Transfus Apher Sci. 2014 Feb;50(1):53-5. doi: 10.1016/j.transci.2013.07.036. Epub 2013 Nov 27.

PMID:
24360843
3.

[Randomized clinical study for two types of recombinant human granulocyte colony-stimulating factor mobilizing peripheral blood and bone marrow stem cells in patients receiving allogeneic hematopoietic stem cell transplantation].

Zhang XH, Huang XJ, Liu DH, Liu KY, Han W, Chen H, Wang FR, Chen YH, Wang JZ, Zhao T, Wang Y, Xu LP.

Zhonghua Yi Xue Za Zhi. 2009 Aug 11;89(30):2116-9. Chinese.

PMID:
20058615
4.

[Collection of hematopoietic progenitor cells from healthy donors].

Bojanić I, Cepulić BG, Mazić S.

Acta Med Croatica. 2009 Jun;63(3):237-44. Review. Croatian.

PMID:
19827352
5.

Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures.

Anderlini P, Przepiorka D, Seong D, Miller P, Sundberg J, Lichtiger B, Norfleet F, Chan KW, Champlin R, Körbling M.

Transfusion. 1996 Jul;36(7):590-5. Erratum in: Transfusion 1997 Jan;37(1):109.

PMID:
8701453
7.

Clinical and ultrasonic evaluation of spleen size during peripheral blood progenitor cell mobilization by filgrastim: results of an open-label trial in normal donors.

Stiff PJ, Bensinger W, Abidi MH, Gingrich R, Artz AS, Nademanee A, Hansen KS, Sobczak C, Cutler C, Bolwell B, Shore TB, Lazarus HM, Yeager AM, Lovelace W, Guo M, Dreiling L.

Biol Blood Marrow Transplant. 2009 Jul;15(7):827-34. doi: 10.1016/j.bbmt.2009.03.015.

8.

Splenic rupture in a patient with acute myeloid leukemia undergoing peripheral blood stem cell transplantation.

Kasper C, Jones L, Fujita Y, Morgenstern GR, Scarffe JH, Chang J.

Ann Hematol. 1999 Feb;78(2):91-2.

PMID:
10089026
9.
10.

Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells.

Becker PS, Wagle M, Matous S, Swanson RS, Pihan G, Lowry PA, Stewart FM, Heard SO.

Biol Blood Marrow Transplant. 1997 Apr;3(1):45-9. Erratum in: Biol Blood Marrow Transplant 1997 Jun;3(2):108.

PMID:
9209740
11.

A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation.

Bishop MR, Tarantolo SR, Geller RB, Lynch JC, Bierman PJ, Pavletic ZS, Vose JM, Kruse S, Dix SP, Morris ME, Armitage JO, Kessinger A.

Blood. 2000 Jul 1;96(1):80-5.

12.
13.

Splenic rupture in a parental donor undergoing peripheral blood progenitor cell mobilization.

Dincer AP, Gottschall J, Margolis DA.

J Pediatr Hematol Oncol. 2004 Nov;26(11):761-3.

PMID:
15543014
14.

Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation.

Giralt S, Escudier S, Kantarjian H, Deisseroth A, Freireich EJ, Andersson BS, O'Brien S, Andreeff M, Fisher H, Cork A, et al.

N Engl J Med. 1993 Sep 9;329(11):757-61.

15.

Acute lung Injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone.

Arimura K, Inoue H, Kukita T, Matsushita K, Akimot M, Kawamata N, Yamaguchi A, Kawada H, Ozak A, Arima N, Te C.

Haematologica. 2005 Mar;90(3):ECR10.

16.

Single-dose pegfilgrastim for the mobilization of allogeneic CD34+ peripheral blood progenitor cells in healthy family and unrelated donors.

Kroschinsky F, Hölig K, Poppe-Thiede K, Zimmer K, Ordemann R, Blechschmidt M, Oelschlaegel U, Bornhauser M, Rall G, Rutt C, Ehninger G.

Haematologica. 2005 Dec;90(12):1665-71.

17.

Splenic rupture in a plasma cell leukemia, mobilized with G-CSF for autologous stem cell transplant.

Funes C, Garcia-Candel F, Majado MJ, González-García C, Bas A, Salido E, Moraleda JM, Morales A.

J Clin Apher. 2010;25(4):223-5. doi: 10.1002/jca.20233.

PMID:
20818717
18.
19.

Allogeneic peripheral blood progenitor cells mobilized by G-CSF (filgrastim) for a second transplant in a patient with acute myeloid leukemia in relapse.

Martínez JA, Picón I, Carral A, de la Rubia J, Sanz GF, Sanz MA.

Bone Marrow Transplant. 1995 Jan;15(1):149-51.

PMID:
7537999
20.

Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes.

Guardiola P, Runde V, Bacigalupo A, Ruutu T, Locatelli F, Boogaerts MA, Pagliuca A, Cornelissen JJ, Schouten HC, Carreras E, Finke J, van Biezen A, Brand R, Niederwieser D, Gluckman E, de Witte TM; Subcommittee for Myelodysplastic Syndromes of the Chronic Leukaemia Working Group of the European Blood and Marrow Transplantation Group.

Blood. 2002 Jun 15;99(12):4370-8.

Supplemental Content

Support Center